コロラド州における膠芽腫の臨床試験
コロラド州内の拠点で、膠芽腫に関する14件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UCHealth University of Colorado Hospital, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Colorado Denver, Aurora
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT03970447Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- UCHealth, Aurora
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05902169A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- Saint Mary's Hospital and Regional Medical Center, Grand Junction
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07452458A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06914128Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital Colorado, Aurora
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital Colorado, Aurora
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Colorado Health Cancer Care, Aurora
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital Colorado, Aurora
被験者募集中早期第1相健康なボランティア歓迎
1歳〜21歳 · 全性別 · 2026/06/29更新 · NCT06333899A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT04678648The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Boulder, Boulder
被験者募集中
18歳以上 · 全性別 · 2026/06/09更新 · NCT07636200Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital Colorado, Aurora
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。